🧬 Retatrutide Peptide — 10 mg / 20 mg / 30 mg

High‑Purity Triple‑Agonist Research Peptide for Metabolic & Receptor‑Signaling Studies (Canada)

Retatrutide is a high‑purity, research‑grade synthetic long‑chain peptide engineered as a triple‑agonist analog targeting GLP‑1 receptor (GLP‑1R), GIP receptor (GIPR), and glucagon receptor (GCGR) signaling pathways. It is widely referenced in laboratory research involving multi‑receptor metabolic signaling, energy‑regulation models, and advanced incretin‑pathway biology.

Supplied by BlueNexLabs, Retatrutide is available as a lyophilized research peptide in 10 mg, 20 mg, and 30 mg fill sizes, with COA‑verified purity, analytical consistency, and audit‑safe Research‑Use‑Only (RUO) labeling, supporting advanced experimental workflows in Canadian research environments.

🔬 Overview of Retatrutide in Research Settings

Retatrutide is designed to support simultaneous investigation of three hormonally linked receptor systems, making it a valuable model compound for exploring how balanced vs. biased receptor activation influences downstream metabolic signaling.

In controlled laboratory settings, Retatrutide is commonly referenced in studies examining:

• Multi‑agonist incretin‑pathway signaling

• Receptor cross‑talk between GLP‑1R, GIPR, and GCGR

• Energy‑regulation and metabolic‑stress adaptation models

• Receptor‑specific vs. integrated transcriptional responses

• Structure–function relationships in long‑chain peptide analogs

Its triple‑agonist architecture enables side‑by‑side comparison of single‑, dual‑, and multi‑receptor activation paradigms.

🧪 What Is Retatrutide?

Retatrutide is a synthetic triple‑agonist research peptide designed for laboratory studies involving concurrent activation of:

• GLP‑1R (glucagon‑like peptide‑1 receptor)

• GIPR (glucose‑dependent insulinotropic polypeptide receptor)

• GCGR (glucagon receptor)

This multi‑receptor engagement allows researchers to investigate coordinated incretin and glucagon pathway signaling within a single experimental system.

In research contexts, Retatrutide supports studies involving:

• Complex metabolic‑signaling integration

• Receptor‑pathway hierarchy and signaling dominance

• Multi‑axis energy‑regulation models

• Synergistic vs. independent receptor activation

📡 Mechanistic Research Overview (Audit‑Safe)

🔵 GLP‑1R‑Linked Signaling

• Referenced in studies examining incretin‑associated transcriptional activity

• Used in models exploring metabolic‑stress signaling pathways

• Supports investigation of receptor‑linked intracellular signaling cascades

🟠 GIPR‑Linked Signaling

• Applied in research involving adipocyte‑associated signaling markers

• Supports studies of incretin‑mediated receptor cross‑talk

• Used in comparative incretin‑pathway modeling

🟣 GCGR‑Linked Signaling

• Examined in glucagon‑associated energy‑mobilization research

• Supports hepatic‑signaling pathway modeling

• Used in receptor‑specific activation studies

🔗 Triple‑Agonist Integration

• Enables analysis of balanced vs. biased receptor activation

• Supports multi‑axis metabolic‑signaling models

• Used in studies exploring synergistic pathway behavior

🧱 Molecular & Chemical Characteristics

Type: Synthetic long‑chain triple‑agonist peptide
Form: Lyophilized powder
Available Fill Sizes: 10 mg / 20 mg / 30 mg
Identity Verification: Mass Spectrometry (MS)
Purity Analysis: HPLC / UPLC

Structural & Biochemical Notes

• Sequence includes stabilizing modifications for protease resistance

• Incorporates a fatty‑acid conjugation region to support albumin association in vitro

• Demonstrates predictable behavior in receptor‑binding and analytical workflows

• Sensitive to hydrolysis and oxidation post‑reconstitution

🔬 Research Focus Areas

Retatrutide is commonly referenced in laboratory research involving:

• Triple‑agonist incretin‑pathway modeling

• GLP‑1R / GIPR / GCGR receptor cross‑talk analysis

• Metabolic‑stress and energy‑balance studies

• Receptor‑specific vs. receptor‑balanced signaling comparisons

• Long‑chain peptide stability and degradation‑resistance assays

• Structure–function analysis of multi‑agonist peptide analogs

Its broad mechanistic scope supports advanced, pathway‑specific metabolic‑biology research in regulated laboratory settings.

❄️ Storage & Handling Guidelines

• Store lyophilized peptide at –20 °C, protected from light and moisture

• Reconstituted solutions: 2–8 °C, short‑term research use only

• Avoid prolonged exposure to room temperature after reconstitution

• Avoid repeated freeze–thaw cycles; aliquot when necessary

• Use sterile preparation techniques and low‑binding labware

📄 Certificate of Analysis & Documentation

Each batch of Retatrutide supplied by BlueNexLabs includes audit‑ready documentation, ensuring traceability and reproducibility:

• Mass Spectrometry identity confirmation

• HPLC / UPLC purity profile

• Solvent system disclosure

• Lot and batch traceability

• Research‑Use‑Only (RUO) designation

🔗 View Certificate of Analysis (COA)
🔗 Learn About Our Testing Standards
🔗 Explore the BlueNexLabs Research Peptide Catalog

🇨🇦 Supplied for Canadian Research Laboratories

BlueNexLabs supplies Retatrutide research peptide to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and throughout Canada.

Why Researchers Choose BlueNexLabs

• 🇨🇦 Canada‑wide domestic shipping

• 📄 COA‑verified, traceable batches

• 🧪 Audit‑safe RUO labeling

• ⚡ Fast fulfillment & responsive support

• 🔬 Research‑focused metabolic‑pathway peptide catalog

⚠️ Compliance Notice

This product is supplied strictly for laboratory research use only (RUO).
Not for human or veterinary use.
No medical, therapeutic, metabolic, diagnostic, or performance‑related claims are made or implied.

✨ GLOW‑70 Research Peptide — 70 mg

High‑Purity Multi‑Peptide Complex for Cellular Signaling & Stress‑Response Research (Canada)

GLOW‑70 is a high‑purity, research‑grade peptide complex supplied as a 70 mg lyophilized formulation and designed for advanced cellular‑signaling, stress‑response, and peptide–protein interaction research. This formulation combines GHK‑Cu, TB‑500, and BPC‑157—three peptides commonly referenced in controlled laboratory research environments for multi‑pathway cellular studies.

Supplied by BlueNexLabs, GLOW‑70 is manufactured and tested to support in‑vitro and preclinical research workflows, offering COA‑verified purity, consistent batch quality, and audit‑safe Research‑Use‑Only (RUO) labeling for Canadian laboratories.

🔬 Overview of GLOW‑70 in Research Settings

GLOW‑70 is formulated to support multi‑mechanism cellular research, where investigators seek to explore how distinct peptide systems interact within complex signaling environments. In laboratory settings, it is frequently referenced in studies examining:

• Cellular‑signaling pathway integration

• Stress‑response and adaptive signaling models

• Peptide–protein and peptide–receptor interactions

• Transcriptional‑cascade and metabolic‑marker analysis

• Comparative multi‑peptide pathway studies

Its combined composition makes GLOW‑70 a useful model system for researchers conducting broad, pathway‑focused cellular investigations.

🧪 What Is GLOW‑70?

GLOW‑70 is a lyophilized research peptide complex (70 mg) intended for laboratory studies involving:

• Cellular signaling and pathway mapping

• Stress‑response and adaptation modeling

• Protein–peptide interaction analysis

• Transcriptional‑activity and metabolic‑marker investigations

• In‑vitro and preclinical research requiring high‑purity peptide materials

Its broad mechanistic scope allows for multi‑pathway experimental design in regulated research environments.

📡 Mechanistic Research Overview (Audit‑Safe)

🔗 Cellular Signaling & Pathway Modulation

• Referenced in studies examining receptor‑level and downstream signaling

• Supports mapping of transcriptional‑cascade activity

• Used in multi‑pathway cellular‑signaling research models

⚡ Stress‑Response & Cellular Adaptation

• Applied in research involving oxidative‑ and metabolic‑stress markers

• Supports investigations into adaptive cellular signaling

• Used in controlled stress‑response modeling systems

🧬 Peptide–Protein & Interaction Dynamics

• Referenced in peptide‑binding and interaction studies

• Supports structural‑modeling and pathway‑integration research

• Used in proliferation‑ and metabolism‑related laboratory assays

🧱 Molecular & Chemical Characteristics

Type: Multi‑component research peptide complex
Form: Lyophilized powder
Fill Size: 70 mg
Purity Verification: HPLC / UPLC
Identity Confirmation: Mass Spectrometry (MS)

Structural & Biochemical Notes

• Designed for predictable behavior in controlled research systems

• Stability influenced by buffer composition and handling technique

• Sensitive to degradation following reconstitution if improperly stored

🔬 Research Focus Areas

GLOW‑70 is commonly referenced in laboratory research involving:

• Cellular‑signaling and transcriptional‑cascade studies

• Stress‑response and oxidative‑marker analysis

• Peptide–protein and interaction‑network modeling

• Proliferation and metabolic‑marker research

• Multi‑pathway peptide comparison and integration studies

Its formulation supports controlled, pathway‑specific experiments requiring high‑purity, reproducible peptide materials.

❄️ Storage & Handling Guidelines

• Store lyophilized peptide at –20 °C, protected from light and moisture

• Reconstituted solutions: 2–8 °C, short‑term research use only

• Avoid repeated freeze–thaw cycles; aliquot where appropriate

• Use sterile technique during preparation

• Employ low‑binding labware when possible

📄 Certificate of Analysis & Documentation

Each batch of GLOW‑70 supplied by BlueNexLabs includes audit‑ready documentation, supporting traceability and reproducibility:

• Mass Spectrometry identity confirmation

• HPLC / UPLC purity profile

• Solvent system disclosure

• Batch and lot traceability

• Research‑Use‑Only (RUO) designation

🔗 View Certificate of Analysis (COA)
🔗 Learn About Our Testing Standards
🔗 Explore the BlueNexLabs Research Peptide Catalog

🇨🇦 Supplied for Canadian Research Laboratories

BlueNexLabs supplies GLOW‑70 research peptide to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and throughout Canada.

Why Researchers Choose BlueNexLabs

• 🇨🇦 Canada‑wide domestic shipping

• 📄 COA‑verified, traceable batches

• 🧪 Audit‑safe RUO labeling

• ⚡ Fast fulfillment & responsive support

• 🔬 Research‑focused peptide catalog

⚠️ Compliance Notice

This product is supplied strictly for laboratory research use only (RUO).
Not for human or veterinary use.
No medical, therapeutic, cosmetic, diagnostic, or performance‑related claims are made or implied.

🧬 Tesamorelin Peptide — 10 mg

High‑Purity GHRH Analog for Endocrine Signaling, Metabolic Pathway & Cellular Regulation Research (Canada)

Tesamorelin is a high‑purity, research‑grade synthetic Growth Hormone–Releasing Hormone (GHRH) analog widely referenced in laboratory research involving pituitary‑axis signaling, GH/IGF‑1‑linked transcriptional pathways, metabolic‑regulation models, and peptide–receptor interaction dynamics.

Supplied by BlueNexLabs, Tesamorelin is provided as a lyophilized peptide (10 mg) with COA‑verified purity, analytical consistency, and audit‑safe Research‑Use‑Only (RUO) labeling, supporting reproducible experimental workflows in Canadian research environments.

🔬 Overview of Tesamorelin in Research Settings

Tesamorelin is a stabilized 44‑amino‑acid GHRH analog designed to support controlled investigation of endocrine‑axis communication and downstream metabolic signaling. In laboratory settings, it is frequently referenced in studies examining:

• Pituitary‑axis and GHRH receptor (GHRH‑R) signaling

• GH/IGF‑1‑associated transcriptional cascades

• Metabolic‑regulation and lipid‑signaling pathways

• Cellular growth and protein‑synthesis models

• Peptide stability and receptor‑binding kinetics

Its receptor specificity and predictable in‑vitro behavior make Tesamorelin a valuable model compound for endocrine and metabolic research.

🧪 What Is Tesamorelin?

Tesamorelin is a synthetic GHRH analog used in laboratory research involving:

• Pituitary‑axis signaling and GH‑pathway activation models

• GHRH‑receptor (GHRH‑R) binding and kinetic analysis

• GH/IGF‑1‑linked transcriptional signaling studies

• Lipid‑metabolism and adipocyte‑signaling research

• Cellular‑growth and protein‑synthesis pathway modeling

• Peptide stability and degradation‑resistance profiling

Its extended stability and receptor‑specific activity support controlled, pathway‑specific experimental design.

📡 Mechanistic Research Overview (Audit‑Safe)

🧬 Endocrine Axis & GHRH‑Receptor Signaling

• Referenced in studies examining GHRH‑R activation

• Used in models mapping GH/IGF‑1‑associated transcriptional cascades

• Supports research into pituitary‑linked cellular communication

⚖️ Metabolic Regulation & Lipid Pathway Modeling

• Applied in research involving lipid‑signaling and metabolic markers

• Supports investigation of adipocyte‑associated signaling pathways

• Used in multi‑pathway metabolic‑regulation studies

🔋 Cellular Growth & Protein Synthesis Dynamics

• Examined in GH‑linked growth‑pathway models

• Supports peptide‑mediated transcriptional activation research

• Used in comparative studies versus other GHRH analogs

🧱 Molecular & Chemical Characteristics

Type: Synthetic 44‑amino‑acid GHRH analog
Form: Lyophilized powder
Fill Size: 10 mg
Origin: Modified GHRH sequence for enhanced stability
Identity Verification: Mass Spectrometry (MS)
Purity Analysis: HPLC / UPLC

Structural & Biochemical Notes

• Designed for predictable receptor‑binding behavior in vitro

• Demonstrates strong stability in lyophilized form

• Sensitive to hydrolysis and degradation following reconstitution if improperly handled

🔬 Research Focus Areas

Tesamorelin is commonly referenced in laboratory research involving:

• Endocrine‑axis and pituitary‑signaling modeling

• GH/IGF‑1‑linked transcriptional pathway studies

• Metabolic‑regulation and lipid‑signaling assays

• Peptide–receptor binding and activation analysis

• Cellular‑growth and protein‑synthesis research

• Multi‑pathway endocrine and metabolic investigations

Its clean mechanistic profile supports controlled, reproducible research workflows in regulated laboratory environments.

❄️ Storage & Handling Guidelines

• Store lyophilized peptide at –20 °C, protected from light and moisture

• Reconstituted solutions: 2–8 °C, short‑term research use only

• Avoid repeated freeze–thaw cycles; aliquot where necessary

• Avoid prolonged exposure to room temperature after reconstitution

• Use sterile preparation techniques and low‑binding labware

📄 Certificate of Analysis & Documentation

Each batch of Tesamorelin supplied by BlueNexLabs includes audit‑ready documentation, ensuring traceability and reproducibility:

• Mass Spectrometry identity confirmation

• HPLC / UPLC purity profile

• Solvent system disclosure

• Lot and batch traceability

• Research‑Use‑Only (RUO) designation

🔗 View Certificate of Analysis (COA)
🔗 Learn About Our Testing Standards
🔗 Explore the BlueNexLabs Research Peptide Catalog

🇨🇦 Supplied for Canadian Research Laboratories

BlueNexLabs supplies Tesamorelin research peptide to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and throughout Canada.

Why Researchers Choose BlueNexLabs

• 🇨🇦 Canada‑wide domestic shipping

• 📄 COA‑verified, traceable batches

• 🧪 Audit‑safe RUO labeling

• ⚡ Fast fulfillment & responsive support

• 🔬 Research‑focused endocrine & metabolic peptide catalog

⚠️ Compliance Notice

This product is supplied strictly for laboratory research use only (RUO).
Not for human or veterinary use.
No medical, therapeutic, metabolic, diagnostic, or performance‑related claims are made or implied.

🧬 CJC‑1295 (No DAC) + Ipamorelin Peptide Blend

Dual‑Pathway GHRH & GHSR‑1a Research Peptides for Endocrine Signaling & Receptor‑Pathway Studies (Canada)

CJC‑1295 (No DAC) + Ipamorelin is a high‑purity, research‑grade dual‑peptide formulation widely referenced in laboratory research involving endocrine signaling, receptor co‑activation, intracellular messenger integration, and peptide‑receptor kinetics.

Supplied by BlueNexLabs, this formulation combines CJC‑1295 (No DAC)—a short‑acting GHRH analog—with Ipamorelin, a selective GHSR‑1a agonist. Together, they support controlled investigation of parallel receptor systems under Research‑Use‑Only (RUO) conditions in Canadian research environments.

🔬 Overview of the CJC‑1295 (No DAC) + Ipamorelin Research Model

This dual‑peptide system is commonly used as a model platform for studying how GHRH receptor (GHRH‑R) signaling and growth hormone secretagogue receptor (GHSR‑1a) signaling behave independently and in combination.

Unlike DAC‑modified peptides, CJC‑1295 (No DAC) lacks a drug‑affinity complex, resulting in short‑window receptor engagement. This property makes it particularly useful for high‑resolution kinetic studies and time‑course experiments focused on pulsatile receptor activation patterns.

When paired with Ipamorelin, researchers can explore dual‑pathway signaling architecture without long‑acting peptide confounders.

🧪 What Is CJC‑1295 (No DAC) + Ipamorelin?

This formulation contains two distinct research peptides:

CJC‑1295 (No DAC)

• Synthetic GHRH analog without DAC modification

• Used in laboratory models of GHRH‑R binding and cAMP‑linked signaling

• Short in‑vitro half‑life supports temporal resolution studies

Ipamorelin

• Selective GHSR‑1a pentapeptide agonist

• Used in studies of Ca²⁺ mobilization and receptor‑bias behavior

• Demonstrates predictable, receptor‑specific signaling in vitro

Together, this combination enables dual‑axis endocrine signaling research under controlled laboratory conditions.

📡 Mechanistic Research Overview (Audit‑Safe)

🧬 Dual‑Receptor Pathway Activation

• Used to study simultaneous GHRH‑R and GHSR‑1a engagement

• Supports analysis of receptor crosstalk and pathway amplification

• Applied in comparative single‑ vs. dual‑receptor studies

⚙️ Intracellular Messenger Integration

• Referenced in research examining cAMP signaling (GHRH‑R)

• Supports studies of Ca²⁺ mobilization (GHSR‑1a)

• Enables mapping of convergent vs. divergent transcriptional responses

🔁 Receptor Bias & Kinetic Behavior

• Applied in assays measuring β‑arrestin recruitment and receptor internalization

• Used for receptor recycling and ligand‑dependent trafficking studies

• Supports short‑window kinetic modeling due to No‑DAC design

🧱 Molecular & Chemical Characteristics

Type: Dual‑peptide research formulation
Form: Lyophilized powder
Fill Size:

• 5 mg CJC‑1295 (No DAC)

• 5 mg Ipamorelin

Identity Verification:

• Each peptide independently verified via Mass Spectrometry (MS)

• Purity confirmed by HPLC / UPLC

Structural & Biochemical Notes

CJC‑1295 (No DAC):

• Short‑acting GHRH analog without albumin‑binding modification

• High solubility in polar buffers

• Stability influenced by pH, ionic strength, and temperature

Ipamorelin:

• Selective GHSR‑1a agonist with low off‑target activity in vitro

• Predictable solubility and low nonspecific binding

• Stability improves in mildly acidic buffer systems

Combined Behavior:

• Supports dual‑axis signaling analysis (cAMP, Ca²⁺, MAPK, CREB)

• Low aggregation risk when properly buffered

• Suitable for time‑course and receptor‑bias experiments

🔬 Research Focus Areas

This dual‑peptide formulation is commonly referenced in research involving:

• Endocrine‑axis and receptor‑coactivation modeling

• GHRH‑R and GHSR‑1a signaling comparison studies

• Intracellular second‑messenger integration

• Receptor‑bias and internalization kinetics

• Peptide–peptide interaction and solubility analysis

• Analytical method development for multi‑peptide systems

Its short‑acting design supports controlled, high‑resolution research workflows.

❄️ Storage & Handling Guidelines

Lyophilized (Unreconstituted)

• Store at –20 °C, protected from light and moisture

• Allow vial to reach room temperature before opening

• Peptides are hygroscopic — minimize humidity exposure

Reconstituted

• Store at 2–8 °C for short‑term research use only

• Prepare minimal working volumes

• Use sterile, low‑binding labware

• Avoid repeated vial punctures

General Handling

• Avoid repeated freeze–thaw cycles; aliquot if needed

• Use appropriate buffer systems to maintain stability

• Minimize oxygen exposure during preparation

📄 Certificate of Analysis & Documentation

Each batch supplied by BlueNexLabs includes audit‑ready documentation, ensuring traceability and reproducibility:

• MS identity confirmation (each peptide)

• HPLC / UPLC purity profiles

• Solvent system disclosure

• Lot and batch traceability

• Research‑Use‑Only (RUO) designation

🔗 View Certificate of Analysis (COA)
🔗 Learn About Our Testing Standards
🔗 Explore the BlueNexLabs Research Peptide Catalog

🇨🇦 Supplied for Canadian Research Laboratories

BlueNexLabs supplies CJC‑1295 (No DAC) + Ipamorelin research peptides to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and throughout Canada.

Why Researchers Choose BlueNexLabs

• 🇨🇦 Canada‑wide domestic shipping

• 📄 COA‑verified, traceable batches

• 🧪 Audit‑safe RUO labeling

• ⚡ Fast fulfillment & responsive support

• 🔬 Research‑focused endocrine‑pathway peptide catalog

⚠️ Compliance Notice

This product is supplied strictly for laboratory research use only (RUO).
Not for human or veterinary use.
No medical, therapeutic, cosmetic, diagnostic, or performance‑related claims are made or implied.